LysoPC (20:4)
LysoPC (20:4) is a type of lysophosphatidylcholine. The level of LysoPC (20:4) is negatively correlated with cancer risk. LysoPC (20:4) may promote tumor progression through the lysophosphatidic acid (LPA) signaling pathway[1].
Product Specifications
CAS Number
60701-99-7
Product Name Alternative
1-Arachidonoyl-sn-glycero-3-phosphocholine
UNSPSC
12352211
Target
Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
C[N+](C)(C)CCOP(OC[C@H](O)COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)([O-])=O
Molecular Formula
C28H50NO7P
Molecular Weight
543.67
References & Citations
[1]Kühn T, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016 Jan 28;14:13.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KN210709 1 Kit
Peroxiredoxin 5 (PRDX5) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC741070-500 1x 500 µL
TRAcP (Tartarate Resistant Acid Phosphatase) (ACP5/1070), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042025-100 1x 100 µL
MMP9 (MMP9/2025R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details